Table 2.
Participant | Age | Genetic testing | Genetic testing result | Risk-reducing surgery | Screening | |
---|---|---|---|---|---|---|
BSO | Mx | |||||
HROC_02 | 38 | No | – | Yes | No | No |
HROC_03 | 42 | Yes | No mutation | Yes | No | No |
HROC_04 | 45 | Yes | No mutation | Yes | No | Yes—until BSO |
HROC_05 | 35 | Yes | BRCA2 +ve | No | Yes | Yes |
HROC_06 | 37 | Yes | BRCA1 +ve | No | No | No |
HROC_07 | 58 | No | – | No | No | Yes |
HROC_08 | 29 | Yes | BRCA1 +ve | No | No | No |
HROC_10 | 25 | Yes | BRCA1 +ve | No | Yes | No |
BSO = bilateral salpingo-oophorectomy, Mx = mastectomy, Screening = transvaginal ultrasound and/or CA125 biomarker, +ve = mutation positive